1. Home
  2. SPOK vs CDXS Comparison

SPOK vs CDXS Comparison

Compare SPOK & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

HOLD

Current Price

$10.65

Market Cap

222.8M

ML Signal

HOLD

Logo Codexis Inc.

CDXS

Codexis Inc.

HOLD

Current Price

$1.42

Market Cap

256.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPOK
CDXS
Founded
2004
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Major Chemicals
Sector
Telecommunications
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
222.8M
256.3M
IPO Year
2004
2008

Fundamental Metrics

Financial Performance
Metric
SPOK
CDXS
Price
$10.65
$1.42
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
146.7K
1.1M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
11.31%
N/A
EPS Growth
2.74
43.82
EPS
0.29
N/A
Revenue
$139,708,000.00
$138,590,000.00
Revenue This Year
$1.70
$7.73
Revenue Next Year
N/A
$14.24
P/E Ratio
$36.76
N/A
Revenue Growth
1.49
32.30
52 Week Low
$9.95
$0.96
52 Week High
$17.67
$2.98

Technical Indicators

Market Signals
Indicator
SPOK
CDXS
Relative Strength Index (RSI) 48.83 36.97
Support Level $10.29 $1.38
Resistance Level $10.85 $1.76
Average True Range (ATR) 0.21 0.11
MACD -0.01 0.01
Stochastic Oscillator 43.18 5.35

Price Performance

Historical Comparison
SPOK
CDXS

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

About CDXS Codexis Inc.

Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.

Share on Social Networks: